These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38852751)

  • 1. Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders.
    Gan C; Cao X; Sun H; Ye S; Shi J; Shan A; Gao M; Wan C; Zhang K; Yuan Y
    Neurobiol Dis; 2024 Aug; 198():106560. PubMed ID: 38852751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resting-state brain networks in patients with Parkinson's disease and impulse control disorders.
    Tessitore A; Santangelo G; De Micco R; Giordano A; Raimo S; Amboni M; Esposito F; Barone P; Tedeschi G; Vitale C
    Cortex; 2017 Sep; 94():63-72. PubMed ID: 28715675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural bases of impulse control disorders in Parkinson's disease: A systematic review and an ALE meta-analysis.
    Santangelo G; Raimo S; Cropano M; Vitale C; Barone P; Trojano L
    Neurosci Biobehav Rev; 2019 Dec; 107():672-685. PubMed ID: 31586557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupted salience network dynamics in Parkinson's disease patients with impulse control disorders.
    Navalpotro-Gomez I; Kim J; Paz-Alonso PM; Delgado-Alvarado M; Quiroga-Varela A; Jimenez-Urbieta H; Carreiras M; Strafella AP; Rodriguez-Oroz MC
    Parkinsonism Relat Disord; 2020 Jan; 70():74-81. PubMed ID: 31881521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal data fusion reveals functional and neurochemical correlates of Parkinson's disease.
    Shi D; Wu S; Zhuang C; Mao Y; Wang Q; Zhai H; Zhao N; Yan G; Wu R
    Neurobiol Dis; 2024 Jul; 197():106527. PubMed ID: 38740347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders.
    Lee JY; Seo SH; Kim YK; Yoo HB; Kim YE; Song IC; Lee JS; Jeon BS
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):23-30. PubMed ID: 24023269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
    Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical thickness changes in patients with Parkinson's disease and impulse control disorders.
    Tessitore A; Santangelo G; De Micco R; Vitale C; Giordano A; Raimo S; Corbo D; Amboni M; Barone P; Tedeschi G
    Parkinsonism Relat Disord; 2016 Mar; 24():119-25. PubMed ID: 26810913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurobiology of impulse control disorders in Parkinson's disease: from neurotransmitters to neural networks.
    Vriend C
    Cell Tissue Res; 2018 Jul; 373(1):327-336. PubMed ID: 29383446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
    Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
    Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incentive-driven decision-making networks in de novo and drug-treated Parkinson's disease patients with impulsive-compulsive behaviors: A systematic review of neuroimaging studies.
    Martini A; Tamburin S; Biundo R; Weis L; Antonini A; Pizzolo C; Leoni G; Chimenton S; Edelstyn NMJ
    Parkinsonism Relat Disord; 2020 Sep; 78():165-177. PubMed ID: 32927414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional correlates of response inhibition in impulse control disorders in Parkinson's disease.
    Esteban-Peñalba T; Paz-Alonso PM; Navalpotro-Gómez I; Rodríguez-Oroz MC
    Neuroimage Clin; 2021; 32():102822. PubMed ID: 34536820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease.
    Tessitore A; De Micco R; Giordano A; di Nardo F; Caiazzo G; Siciliano M; De Stefano M; Russo A; Esposito F; Tedeschi G
    Mov Disord; 2017 Dec; 32(12):1710-1719. PubMed ID: 28949049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal interhemispheric resting state functional connectivity in Parkinson's disease patients with impulse control disorders.
    Gan C; Wang L; Ji M; Ma K; Sun H; Zhang K; Yuan Y
    NPJ Parkinsons Dis; 2021 Jul; 7(1):60. PubMed ID: 34272398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Salient and Corticolimbic Connectivity in Hypersexual Parkinson's Disease.
    Mata-Marín D; Pineda-Pardo JA; Molina JA; Vela L; Alonso-Frech F; Obeso I
    Brain Connect; 2021 Oct; 11(8):639-650. PubMed ID: 33813866
    [No Abstract]   [Full Text] [Related]  

  • 16. Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson's disease.
    Maggi G; Loayza F; Vitale C; Santangelo G; Obeso I
    J Neurol; 2024 May; 271(5):2798-2809. PubMed ID: 38416170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Imaging and Impulse Control Disorders in Parkinson's Disease.
    Roussakis AA; Lao-Kaim NP; Piccini P
    Curr Neurol Neurosci Rep; 2019 Aug; 19(9):67. PubMed ID: 31396719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of brain metabolism in recently diagnosed Parkinson's impulse control disorders.
    Marín-Lahoz J; Sampedro F; Horta-Barba A; Martínez-Horta S; Aracil-Bolaños I; Camacho V; Bejr-Kasem H; Pascual-Sedano B; Pérez-Pérez J; Gironell A; Pagonabarraga J; Carrió I; Kulisevsky J
    Eur J Nucl Med Mol Imaging; 2020 Aug; 47(9):2165-2174. PubMed ID: 31897582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive functioning and risk-taking behavior in Parkinson's disease patients with impulse control disorders.
    Pineau F; Roze E; Lacomblez L; Bonnet AM; Vidailhet M; Czernecki V; Corvol JC
    J Neural Transm (Vienna); 2016 Jun; 123(6):573-81. PubMed ID: 27085342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphometric alterations of the mesocorticolimbic network in Parkinson's disease with impulse control disorders.
    Ansari MF; Prasad S; Bhardwaj S; Kamble N; Rakesh K; Holla VV; Yadav R; Mahale RR; Saini J; Pal PK
    J Neural Transm (Vienna); 2024 Mar; 131(3):229-237. PubMed ID: 38216706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.